The 340B-program landscape has changed dramatically. For the 340B program’s first 28 years after its 1992 inception, the basic list of Best Practices for eligible entities (the 340B basics, if you will) remained largely unchanged — aside from the dramatically-increased importance of using specialized software. But since the June, 2020 introduction of 340B ESP — … Read More
Drug Manufacturer Restrictions
Why 340B Hospitals Should Now Build Their Own Specialty Pharmacies
340B ESP and drug manufacturer restrictions are only part of the reason As we noted in a previous post, for 340B-eligible hospitals dealing with increasingly squeezed bottom lines, an in-house specialty pharmacy offers enormous savings and revenue potential. Some covered entities generate as much as 600% in specialty pharmacy revenue from 340B drugs as they … Read More
Manufacturers Accelerate Pace And Severity Of 340B Drug Pricing Restrictions
There’s an old saying that it’s better to be rich and guilty than poor and innocent. It’s a sad truth that accurately reflects the current state of 340B manufacturer restrictions, particularly in the wake of the January 30, 2023 decision by the U.S. Court of Appeals for the Third Circuit — which was largely in … Read More
Brick Walls: Dealing With 340B Manufacturer Restrictions.
A VytlOne Team Member Speaks Out. I joined VytlOne in early 2021, and I’ve been devoted to 340B program management full-time since early 2022. I’m no stranger to heavily regulated programs. Nearly my whole professional career has been in some aspect of public health — preclinical, clinical and now post-clinical. I’m currently fully devoted to … Read More
How VytlOne Quadrupled One 340B Entity’s Savings & Revenue In A Single Quarter
In late 2022, VytlOne’s team initiated 340B Program-Management support for a regional non-profit medical center located in the Northeast. We began actively submitting eligible prescriptions in January, 2023. By the end of Q1, the hospital’s 2023 340B savings & revenue had surpassed its total for all of 2022. Below is a brief review of how … Read More
The Shame Of 340B ESP and Drug Manufacturer Restrictions
Making the rich richer at the expense of the poorest and most vulnerable. Why was the 340B program created? Nobody’s ever put it better than the Association of American Medical Colleges (AAMC): “Congress created the 340B Drug Pricing Program in 1992 to protect safety-net hospitals from escalating drug prices by allowing them to purchase outpatient … Read More
Understanding The 340B Program Requirements
POST OUTLINE 1) What Is The 340B Drug Pricing Program? How does the 340B program work? How much revenue can my hospital generate from the 340B program? 2) Who qualifies for the 340B program? What is a 340B Covered Entity? Facilities included in the 340B program 3) Understanding the 340B program requirements for eligibility Government-owned … Read More







